Package 55150-513-01

{"route": ["INTRAMUSCULAR", "INTRATHECAL", "INTRAVENOUS", "SUBCUTANEOUS"], "spl_id": "adc6f7e8-b3a3-476a-9939-0c5cbda63dbd", "openfda": {"upc": ["0355150510016", "0355150510054", "0355150511013"], "unii": ["3IG1E710ZN"], "rxcui": ["1655959", "1655960", "1655967", "1655968"], "spl_set_id": ["63bb6fbf-dd59-4edc-af8f-d0c397ca1262"], "manufacturer_name": ["Eugia US LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL in 1 CARTON (55150-513-01)  / 10 mL in 1 VIAL", "package_ndc": "55150-513-01", "marketing_start_date": "20240911"}], "brand_name": "METHOTREXATE", "product_id": "55150-513_adc6f7e8-b3a3-476a-9939-0c5cbda63dbd", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Folate Analog Metabolic Inhibitor [EPC]", "Folic Acid Metabolism Inhibitors [MoA]"], "product_ndc": "55150-513", "generic_name": "METHOTREXATE", "labeler_name": "Eugia US LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "METHOTREXATE", "active_ingredients": [{"name": "METHOTREXATE SODIUM", "strength": "250 mg/10mL"}], "application_number": "ANDA201529", "marketing_category": "ANDA", "marketing_start_date": "20240911", "listing_expiration_date": "20261231"}